Advances in Nanotheranostics II (Record no. 81077)

000 -LEADER
fixed length control field 03522nam a22005775i 4500
001 - CONTROL NUMBER
control field 978-981-10-0063-8
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220801222720.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160111s2016 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9789811000638
-- 978-981-10-0063-8
082 04 - CLASSIFICATION NUMBER
Call Number 610.28
245 10 - TITLE STATEMENT
Title Advances in Nanotheranostics II
Sub Title Cancer Theranostic Nanomedicine /
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2016.
300 ## - PHYSICAL DESCRIPTION
Number of Pages XI, 381 p. 158 illus., 17 illus. in color.
490 1# - SERIES STATEMENT
Series statement Springer Series in Biomaterials Science and Engineering,
520 ## - SUMMARY, ETC.
Summary, etc This book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China.
700 1# - AUTHOR 2
Author 2 Dai, Zhifei.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://doi.org/10.1007/978-981-10-0063-8
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks
264 #1 -
-- Singapore :
-- Springer Nature Singapore :
-- Imprint: Springer,
-- 2016.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical engineering.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Nanotechnology.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Radiology.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomaterials.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Oncology.
650 14 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomedical Engineering and Bioengineering.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Nanotechnology.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Radiology.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Biomaterials.
650 24 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Oncology.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
-- 2195-0652 ;
912 ## -
-- ZDB-2-ENG
912 ## -
-- ZDB-2-SXE

No items available.